openPR Logo
Press release

Exponential Growth Expected for Parp Inhibitor Market Current Status and Strategic Forecasting Insights 2024 - 2031 |AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline Plc., Pfizer

08-02-2024 09:15 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Parp Inhibitor Market

Parp Inhibitor Market

A recent report from Coherent Market Insight titled "Parp Inhibitor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031" presents a thorough examination of the industry landscape, offering insights into market analysis and trends. Alongside competitor and regional analysis, the report delves into contemporary advancements within the market.

Global PARP inhibitor market is estimated to be valued at USD 7.20 Bn in 2024 and is expected to reach USD 13.02 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

With a comprehensive table of contents, figures, tables, and charts, this report provides insightful analysis on the Parp Inhibitor market. The industry has witnessed significant growth in recent years, propelled by factors such as heightened product demand, an expanding customer base, and technological progress. Covering market size, trends, drivers, constraints, competitive aspects, and future growth prospects, the report offers a holistic view of the Parp Inhibitor market.

The aim of this market research study is to conduct a thorough investigation of the industry, shedding light on its economic potential. By providing insights into past, present, and prospective aspects of the market, clients gain a complete understanding of market dynamics, enabling informed resource allocation and investment decisions.

Click Here to Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/3037?utm_source=openpr.com&utm_medium=referral

The report covers extensive competitive intelligence which includes the following data points:

✔ Market size from 2024 to 2031
✔ Expected market growth until 2031
✔ Supplier and Demand Analysis
✔ Detailed analysis on market Drivers, Restraints, and Future Opportunities, and Trends of the industry.
✔ Cross sectional analysis for all the Segments, across regions and 30 countries.
✔ Competitive landscape comprising of Company Market Share Analysis and Snapshot of Key Players.
✔ In-depth analysis on financials and sustainability strategies adopted by market players.
✔ Analyst recommendations

Major market players included in this report are:

◘ AstraZeneca Plc.
◘ Johnson & Johnson
◘ GlaxoSmithKline Plc.
◘ Pfizer Inc.
◘ Clovis Oncology Inc.
◘ AbbVie Inc.
◘ Bristol Myers Squibb
◘ Merck KGaA
◘ Genentech Inc.
◘ Artios Pharma
◘ Repare Therapeutics Inc.
◘ Sierra Oncology Inc.
◘ KaryopharmTherapeutics Inc.
◘ Ono Pharmaceutical Co., Ltd.,
◘ Jiangsu Hengrui Medicine Co., Ltd.,

The detailed segments and sub-segment of the market are explained below:

Geographically, the detailed analysis of consumption, revenue, Parp Inhibitor Market share, growth rate, etc. of the following regions:

1) North America (United States, Canada, and Mexico)
2) Europe (Germany, France, UK, Russia, Italy)
3) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
4) South America (Brazil, Argentina, Colombia)
5) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Purchase this Complete Market Report and Get Special Discount at: : https://www.coherentmarketinsights.com/insight/buy-now/3037

Key Highlights of the Parp Inhibitor Market Report:

👉 Compound Annual Growth Rate (CAGR) projections for the entire forecast period.

👉 In-depth analysis of growth drivers shaping the Parp Inhibitor Market between 2024 and 2031.

👉 Accurate assessment of market size and its contribution, including insights into the parent market.

👉 Realistic forecasts of future trends and shifts in consumer behavior.

👉 Comprehensive examination of the competitive landscape and detailed vendor profiles.

👉 Thorough exploration of factors hindering the expansion of Parp Inhibitor Market vendors.

Benefits of Purchase the Parp Inhibitor Market Report:

🎯 Analyst Support: Access expert analysts to address queries before and after purchasing the report.

🎯 Customer Satisfaction: Receive tailored support to meet your research needs and customize the report.

🎯 Unparalleled Expertise: Gain deep insights from our analysts' inimitable industry knowledge.

🎯 Assured Quality: Rest assured of the report's quality and accuracy as we prioritize these aspects.

The report answers a number of crucial questions, including:

➥ Which companies dominate the global Parp Inhibitor market?
➥ What current trends will influence the market over the next few years?
➥ What are the market's opportunities, obstacles, and driving forces?
➥ What predictions for the future can help with strategic decision-making?
➥ What advantages does market research offer businesses?
➥ Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?
➥ What is the anticipated growth rate for the Parp Inhibitor market economy globally?

Author Bio:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/3037

Some of the Major Points of TOC cover:

Chapter 1: Techniques & Scope

1.1 Definition and forecast parameters
1.2 Methodology and forecast parameters
1.3 Information Sources

Chapter 2: Latest Trends Summary

2.1 Regional trends
2.2 Product trends
2.3 End-use trends
2.4 Business trends

Chapter 3: Industry Insights

3.1 Industry fragmentation
3.2 Industry landscape
3.3 Vendor matrix
3.4 Technological and Innovative Landscape

Chapter 4: Parp Inhibitor Market, By Region

Chapter 5: Company Profiles

5.1 Company Overview
5.2 Financial elements
5.3 Product Landscape
5.4 SWOT Analysis
5.5 Systematic Outlook

Chapter 6: Assumptions and Acronyms

Chapter 7: Research Methodology

Chapter 8: Contact (Continue . . .)

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Australia:+61-2-4786-0457
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exponential Growth Expected for Parp Inhibitor Market Current Status and Strategic Forecasting Insights 2024 - 2031 |AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline Plc., Pfizer here

News-ID: 3608115 • Views:

More Releases from Coherent Market Insights

Codeine Market Set for Rapid Growth, Demand, Scope, Size, Share, Forecast 2033 | AcelRx Pharmaceuticals • Amgen • AbbVie
Codeine Market Set for Rapid Growth, Demand, Scope, Size, Share, Forecast 2033 | …
Coherent Market Insights has released a report titled "Codeine Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤ Get Sample Copy of
Toilet Paper Market Size 2026, Emerging Demand, Share & Forecast Through 2033| Georgia-Pacific • Scott Paper • Cascades
Toilet Paper Market Size 2026, Emerging Demand, Share & Forecast Through 2033| G …
The latest study by Coherent Market Insights, titled "Toilet Paper Market Size, Share & Trends Forecast 2026-2033," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2026 and 2033. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants
Group Health Insurance Market Size 2026 Emerging Demands, Share, Trends, Futuristic Opportunity, Share and Forecast To 2033 | UnitedHealth Group, Anthem (Elevance Health), Aetna (CVS Health), Cigna
Group Health Insurance Market Size 2026 Emerging Demands, Share, Trends, Futuris …
The global group health insurance market is estimated to be valued at USD 3.11 Tn in 2025 and is expected to reach USD 5.87 Tn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032. The latest report by Coherent Market Insights indicates strong growth potential for the Group Health Insurance Market from 2026 to 2033, supported by rising industry demand, expanding applications, and ongoing
Material Handling Equipment Market Forecast Indicates Strong Growth Through 2033 |BEUMER GROUP, Daifuku Co., Ltd., Honeywell International
Material Handling Equipment Market Forecast Indicates Strong Growth Through 2033 …
The global material handling equipment market is estimated to be valued at USD 242.51 Bn in 2025 and is expected to register a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032, reaching USD 369.73 Bn by 2032. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Material Handling Equipment Market. From

All 5 Releases


More Releases for Parp

PARP Inhibitors Market Report- Expansive Coverage on the Profit Sources
The global PARP Inhibitors Market Size is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 15.5 Billion by the year 2034 at a 15.2% CAGR during the forecast period for 2025-2034. Request For Free Sample Pages : https://www.insightaceanalytic.com/request-sample/1169 Poly (ADP-ribose) polymerase (PARP) inhibitors target a family of 17 enzymes responsible for catalyzing the formation of ADP-ribose chains (PAR chains) and transferring them to specific target proteins. These enzymes
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA. Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html Global PARP Inhibitors Market: Competition Landscape Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib. The report analyses the global Lynparza market in detail along with the regional analysis as